Meta tags:
description=CAP TODAY, the monthly publication of the College of American Pathologists: news on clinical laboratory tests, instruments, management, and regulation.;

Headings (most frequently used words):

and, pathology, for, in, the, cap, to, today, of, on, selected, abstracts, 2026, clinical, from, news, product, guides, up, president, desk, instruments, webinars, sponsored, roundtables, interactive, magazine, here, new, 325, waukegan, road, northfield, il, 60093, or, current, issue, all, her2, solid, tumors, ai, privacy, with, more, industry, collection, comprehensive, mutation, august, our, feature, follow, gets, fda, anatomic, molecular, column, newsbytes, put, it, board, columns, guide, laboratory, medicine, register, now, subspecialties, manage, subscription, receive, please, subscribe, change, address, mail, information, circulation, 2750, visit, one, guidebook, what, consider, reporting, germline, vus, close, amyloid, detection, fibril, typing, practice, hipaa, loophole, need, caution, dpa, leaders, digitization, deployment, amp, case, report, is, undifferentiated, sarcoma, ewsr1, pou5f1, fusion, molecularly, defined, entity, articles, why, speed, matters, expanding, role, rapid, ngs, precision, oncology, assessment, hba1c, patients, hemoglobin, variants, where, quality, begins, real, impact, blood, choices, support, infectious, disease, diagnostics, public, health, value, incorporating, house, genomic, profiling, into, your, setting, october, ras, action, single, targeted, class, september, 24, simplifying, digital, getting, started, without, complex, rollout, 26, part, foundation, gastric, cancer, asco, guideline, significance, 20, use, view, compare, software, systems, by, innovation, as, problem, solvers, test, consolidation, needs, experts, talk, sequencing, platforms, pressures, billing, pros, prior, authorization, burden, beyond, reaching, workflow, efficiencies, urinalysis, esr1, testing, questions, trial, forge, ahead, hold, hpv, self, risk, management, elevated, formal, framework, agilent, acquire, proscia, 270, million, horiba, yumizen, h550, hematology, analyzer, 510, clearance, siemens, healthineers, launches, innovance, dimer, assay, clears, cepheid, xpert, respiratory, panel, tempus, approval, tumor, only, cdx, quick, links, sign, contact, us, rights, reserved, policy, roundtable, discussions, featured, chemistry, immunoassay, analyzers, mid, high, volume, labs, marketplace,

Text of the page (most frequently used words):
and (57), the (56), for (29), cap (24), #pathology (24), today (20), 2026 (20), cancer (17), clinical (14), webinar (13), #laboratory (12), from (11), her2 (11), with (10), diagnostic (9), analyzers (9), systems (9), not (9), molecular (8), may (8), breast (8), next (7), fda (7), new (7), testing (7), publisher (7), bob (7), mcgonnagle (7), chemistry (7), director (7), register (7), now (7), more (6), all (6), selected (6), abstracts (6), immunoassay (6), september (6), phd (6), product (5), october (5), sequencing (5), assay (5), solid (5), hematology (5), accreditation (5), quality (5), fish (5), this (5), volume (5), sponsored (5), medical (5), medicine (5), moderated (5), does (5), endorse (5), any (5), products (5), services (5), named (5), within (5), our (4), webinars (4), jobs (4), anatomic (4), tumor (4), companion (4), patients (4), panel (4), siemens (4), healthineers (4), news (4), are (4), when (4), big (4), little (4), ponds (4), experts (4), instruments (4), roche (4), information (4), guides (4), tumors (4), diagnostics (4), oncology (4), associate (4), center (4), fusion (4), program (4), being (4), cme (4), university (4), hear (4), discuss (4), ihc (4), search (3), submit (3), marketplace (3), pathologists (3), president (3), desk (3), board (3), has (3), tempus (3), cdx (3), based (3), gets (3), clears (3), respiratory (3), agilent (3), million (3), collection (3), mutation (3), urinalysis (3), test (3), roundtables (3), will (3), how (3), laboratories (3), mid (3), high (3), coagulation (3), low (3), comprehensive (3), which (3), significance (3), one (3), global (3), astrazeneca (3), memorial (3), sloan (3), kettering (3), detection (3), practice (3), was (3), used (3), assurance (3), november (3), presenter (3), staining (3), tuesday (3), made (3), possible (3), special (3), educational (3), grant (3), can (2), compare (2), press (2), 325 (2), waukegan (2), road (2), northfield (2), 60093 (2), privacy (2), youtube (2), linkedin (2), follow (2), question (2), general (2), subscribe (2), magazine (2), events (2), put (2), newsbytes (2), column (2), columns (2), approval (2), only (2), tissue (2), profiling (2), targeted (2), cepheid (2), xpert (2), launches (2), innovance (2), dimer (2), horiba (2), yumizen (2), h550 (2), analyzer (2), 510 (2), clearance (2), acquire (2), proscia (2), 270 (2), industry (2), edition (2), risk (2), assessment (2), process (2), management (2), years (2), drug (2), approved (2), first (2), hpv (2), self (2), use (2), cytology (2), there (2), what (2), researchers (2), esr1 (2), current (2), issue (2), billing (2), guide (2), diasorin (2), spoke (2), their (2), conversation (2), featured (2), instrumentation (2), gen (2), lab (2), poc (2), accounts (2), receivable (2), rcm (2), computer (2), view (2), feature (2), interactive (2), nearly (2), other (2), part (2), foundation (2), august (2), digital (2), class (2), your (2), support (2), impact (2), variants (2), roundtable (2), discussion (2), solutions (2), head (2), affairs (2), johnson (2), department (2), mark (2), role (2), precision (2), reporting (2), metastatic (2), receive (2), here (2), manage (2), subscription (2), subspecialties (2), daiichi (2), sankyo (2), inc (2), speaker (2), compensated (2), presentation (2), accredited (2), presenters (2), texas (2), saskatchewan (2), canadian (2), biomarker (2), oncopathology (2), assessments (2), absence (2), scoring (2), membrane (2), professor (2), attending (2), expert (2), nrg1 (2), rna (2), hnscc (2), ovarian (2), leader (2), team (2), expression (2), you, add, type, above, cancel, esc, enter, rights, reserved, policy, advertising, letter, editor, request, contact, sign, quick, links, 147, 766, granted, indication, generation, platform, 648, gene, intended, malignancies, also, serves, identify, colorectal, who, benefit, therapies, specifically, erbitux, cetuximab, vectibix, panitumumab, 246, checklist, 2025, released, last, december, emphasis, prospective, elevated, formal, framework, two, after, food, administration, devices, physicians, cervical, prevention, advocates, debating, best, screening, option, forge, ahead, hold, comes, mutations, its, emergence, advanced, still, deciding, stripe, rather, specialists, midst, figuring, out, potentially, important, uses, questions, trial, reaching, workflow, efficiencies, pros, prior, authorization, burden, beyond, talk, platforms, pressures, consolidation, needs, july, cobas, mass, spec, solution, display, month, adlm, meeting, liaison, nes, atellica, 250, much, online, late, representatives, sebia, about, solve, some, pressing, problems, follows, innovation, problem, solvers, labs, billling, software, post, job, founding, ago, organization, had, focus, that, sets, apart, societies, commitment, those, very, familiar, widely, considered, gold, standard, deemed, status, accredit, under, improvement, amendments, regulations, gastric, asco, guideline, simplifying, getting, started, without, complex, rollout, ras, action, single, value, incorporating, house, genomic, into, setting, infectious, disease, public, health, where, begins, real, blood, choices, hba1c, hemoglobin, pillar, biosciences, watch, full, series, virtual, speaks, vendors, spotlight, company, customer, work, scientific, executive, partnering, development, operations, service, mbs, thoracic, oncologist, isabel, preeshagul, ewalt, flora, berisha, john, longshore, why, speed, matters, expanding, rapid, ngs, discussions, biofire, panels, get, ivdr, project, santa, adds, three, members, qiastat, bacteria, articles, amp, case, report, undifferentiated, sarcoma, molecularly, defined, entity, ewsr1, pou5f1, dpa, leaders, digitization, deployment, hipaa, loophole, need, caution, close, amyloid, fibril, typing, heidi, rehm, examined, than, results, they, found, astonishing, rate, inconclusive, reports, due, uncertain, third, multigene, consider, germline, vus, gulisa, turashvili, though, memory, many, once, time, immunohistochemistry, relatively, uncomplicated, matter, back, 1998, both, trastuzumab, herceptin, herceptest, determine, whether, could, guidebook, please, change, address, mail, circulation, 2750, visit, point, care, microbiology, technology, immunology, histotechnology, hematopathology, chair, investigational, therapeutics, institute, personalized, therapy, anderson, houston, college, saskatoon, canada, deputy, programme, canadien, qualité, des, biomarqueurs, carol, cheung, frcpc, emina, torlakovic, funda, meric, bernstam, multidisciplinary, approach, monday, nevada, jeffrey, gregg, join, session, help, improve, accuracy, faint, incomplete, cells, detected, mbc, diaceutics, physician, specializing, gastrointestinal, benjamin, weinberg, challenges, detecting, fusions, identification, genomics, cytopathology, california, san, francisco, georgios, deftereos, evolving, thursday, fellowship, pathologist, hannah, wen, keith, wharton, review, biological, continuum, providing, clearer, understanding, these, variations, might, diagnosis, emerging, importance, documenting, ultralow, categories, using, validated, forum, take, closer, look, interpretation, advancing, through, practical, considerations, navigating, protein, issues, launch,

Text of the page (random words):
cap today pathology and laboratory medicine news cap today pathology and laboratory medicine news linkedin youtube search launch digital edition all issues subspecialties product guides webinars register now jobs events for pathologists manage subscription webinars and sponsored roundtables register now webinar navigating her2 protein expression in breast cancer webinar pd l1 testing in hnscc and ovarian cancer practical considerations for pathologists webinar advancing precision oncology through rna based fusion detection nrg1 fusion testing webinar take a closer look her2 ihc 0 staining interpretation scoring and reporting in metastatic breast cancer webinar oncopathology forum her2 assessments for solid tumors in the absence of a companion diagnostic tuesday october 20 2026 11 am 12 pm et hear experts review the biological and clinical significance of the her2 expression continuum in breast tissue providing a clearer understanding of how these variations might impact diagnosis and discuss the emerging importance of documenting her2 low and her2 ultralow categories using a validated ihc assay webinar presenters keith wharton md phd global medical affairs leader pathology roche diagnostics solutions and hannah y wen md phd director breast pathology fellowship associate team leader breast pathology team attending pathologist memorial sloan kettering cancer center cap today does not endorse any of the products or services named within the webinar is made possible by a special educational grant from roche moderated by bob mcgonnagle publisher cap today register now thursday october 29 2026 1 pm 2 pm et hear an expert discuss the evolving role of pd l1 testing in hnscc and ovarian cancer webinar presenter georgios deftereos md professor of pathology associate director of the clinical cancer genomics laboratory director of molecular cytopathology university of california san francisco cap today does not endorse any of the products or services named within the webinar is made possible by a special educational grant from agilent moderated by bob mcgonnagle publisher cap today register now tuesday november 3 2026 1 pm 2 pm et hear an expert discuss the challenges of detecting nrg1 fusions and how rna based testing can support more comprehensive fusion identification in clinical practice webinar presenter benjamin weinberg md associate professor of medicine and attending physician specializing in gastrointestinal medical oncology cap today does not endorse any of the products or services named within the webinar is made possible by a special educational grant from diaceutics moderated by bob mcgonnagle publisher cap today register now tuesday november 10 2026 1 pm 2 pm et join us for a session to help improve diagnostic accuracy in your practice when scoring her2 ihc 0 with faint incomplete membrane staining in 10 of tumor cells vs ihc 0 with no membrane staining detected in patients with mbc webinar presenter jeffrey gregg md university of nevada cap today does not endorse any of the products or services named within this program is being sponsored by daiichi sankyo inc and astrazeneca the speaker is being compensated for the presentation the program is not cme accredited and may not be used for cme accreditation moderated by bob mcgonnagle publisher cap today register now monday november 16 2026 12 30 pm 2 pm et hear experts discuss a multidisciplinary approach to oncopathology for her2 assessments for solid tumors in the absence of a companion diagnostic webinar presenters funda meric bernstam md chair department of investigational cancer therapeutics medical director institute for personalized cancer therapy the university of texas md anderson cancer center houston texas and emina e torlakovic md phd college of medicine university of saskatchewan canadian biomarker quality assurance saskatoon saskatchewan canada and carol cheung md phd jd frcpc deputy director canadian biomarker quality assurance programme canadien d assurance de la qualité des biomarqueurs cap today does not endorse any of the products or services named within this program is being sponsored by daiichi sankyo inc and astrazeneca the speaker is being compensated for the presentation the program is not cme accredited and may not be used for cme accreditation moderated by bob mcgonnagle publisher cap today register now subspecialties clinical chemistry clinical pathology coagulation cytology hematology hematopathology histotechnology immunoassay immunology information technology microbiology molecular pathology pathology point of care testing interactive product guides anatomic pathology computer systems billing accounts receivable rcm systems chemistry and immunoassay analyzers mid and high volume chemistry and immunoassay analyzers poc and low volume coagulation analyzers hematology analyzers lab information systems next gen sequencing systems urinalysis instrumentation manage subscription to receive cap today magazine please subscribe here for change of address mail new information to cap today circulation 325 waukegan road northfield il 60093 2750 or visit here current issue one for all her2 guidebook for solid tumors september 2026 though it may test the memory of many there once was a time when her2 immunohistochemistry was a relatively uncomplicated matter back in september 1998 the fda approved both trastuzumab herceptin and the first companion diagnostic assay herceptest which was used to determine whether patients with metastatic breast cancer could receive the new drug dr gulisa turashvili what to consider in reporting germline vus september 2026 when heidi rehm phd and other researchers examined more than 1 5 million diagnostic sequencing test results from 19 clinical laboratories they found an astonishing rate of inconclusive reports due to variants of uncertain significance nearly a third in diagnostic multigene panel testing close up on amyloid detection and fibril typing ai privacy and pathology practice hipaa loophole and the need for caution dpa leaders on digitization ai and deployment amp case report is undifferentiated sarcoma with ewsr1 pou5f1 fusion a molecularly defined entity more articles industry news agilent to acquire proscia for up to 270 million horiba yumizen h550 hematology analyzer gets 510 k clearance siemens healthineers launches innovance d dimer 2 0 assay fda clears cepheid xpert respiratory panel fda clears qiastat dx bacteria detection panel project santa fe foundation adds three board members biofire respiratory panels get ivdr class d ce mark sponsored roundtable discussions why speed matters the expanding role of rapid ngs in precision oncology october 2026 this discussion is part of a series of one on one virtual roundtables in which cap today publisher bob mcgonnagle speaks with vendors and laboratory experts to spotlight a company and a customer for their laboratory solutions and work he spoke on september 30 2026 with john longshore phd head of scientific affairs global oncology diagnostics astrazeneca flora berisha executive director global head of diagnostic partnering and development johnson johnson mark d ewalt md associate medical director for laboratory operations diagnostic molecular pathology molecular diagnostics service department of pathology and laboratory medicine memorial sloan kettering cancer center and isabel preeshagul do mbs thoracic medical oncologist memorial sloan kettering cancer center watch the full conversation this roundtable discussion is sponsored by pillar biosciences assessment of hba1c in patients with hemoglobin variants where quality begins the real impact of blood collection choices in support of infectious disease diagnostics and public health cap today webinars the value in incorporating in house comprehensive genomic profiling into your clinical setting october 1 2026 ras in action from a single mutation to a targeted class september 24 2026 simplifying digital pathology getting started without a complex rollout august 26 2026 part 2 foundation of her2 gastric cancer asco cap guideline and significance in solid tumors august 20 2026 columns from the president s desk september 2026 from the cap s founding nearly 80 years ago our organization has had a focus that sets us apart from all other pathology societies our commitment to laboratory quality those of us in the u s are very familiar with the cap accreditation process which is widely considered the gold standard in laboratory accreditation as the cap has deemed status to accredit clinical laboratories under the u s clinical laboratory improvement amendments regulations clinical pathology selected abstracts anatomic pathology selected abstracts molecular pathology selected abstracts q a column newsbytes put it on the board marketplace featured jobs view all jobs post a job interactive product guides use our comprehensive guides to view and compare instruments and software systems feature by feature anatomic pathology computer systems billling accounts receivable rcm systems chemistry and immunoassay analyzers poc and low volume chemistry and immunoassay analyzers for mid and high volume coagulation analyzers hematology analyzers lab information systems next gen sequencing systems urinalysis instrumentation featured guide chemistry immunoassay analyzers for mid and high volume labs new instruments innovation as problem solvers clinical chemistry july 2026 roche s new cobas mass spec solution will be on display this month at the adlm meeting as will diasorin s new liaison nes siemens healthineers atellica dt 250 and much more cap today publisher bob mcgonnagle spoke online in late may with representatives of roche diasorin sebia and siemens healthineers about how their instruments will solve some of laboratories pressing problems the conversation follows product guide roundtables instruments test consolidation and clinical needs experts talk sequencing platforms and pressures billing pros on prior authorization burden and beyond reaching for workflow efficiencies in urinalysis search current issue esr1 mutation testing questions follow trial molecular pathology may 2026 when it comes to cancer mutations there are big fish in little ponds and little fish in big ponds and big fish in big ponds and little fish in little ponds the esr1 mutation and its emergence in advanced breast cancer is still deciding what stripe of fish it is or rather breast specialists researchers and the fda are in the midst of figuring out potentially important uses forge ahead or hold on hpv self collection cytology may 2026 two years after the food and drug administration approved the first hpv self collection devices physicians and cervical cancer prevention advocates are debating the best use for the new screening option risk management elevated to more formal framework clinical pathology may 2026 in the laboratory general accreditation checklist in the 2025 edition released last december is new emphasis on a prospective risk assessment process in the laboratory s quality management 1 2 3 6 next industry news agilent to acquire proscia for up to 270 million horiba yumizen h550 hematology analyzer gets 510 k clearance siemens healthineers launches innovance d dimer 2 0 assay fda clears cepheid xpert respiratory panel 1 2 3 246 next marketplace tempus gets fda approval for tumor only cdx october 2026 the fda has granted approval for a tumor only indication for tempus ai s xt cdx next generation sequencing platform tempus xt cdx is a 648 gene tissue based assay intended for molecular profiling of all solid tumor malignancies it also serves as a companion diagnostic to identify colorectal cancer patients who may benefit from targeted therapies specifically erbitux cetuximab and vectibix panitumumab 1 2 3 2 766 next columns from the president s desk clinical pathology selected abstracts anatomic pathology selected abstracts molecular pathology selected abstracts q a column newsbytes put it on the board from the president s desk 1 2 3 147 next quick links events for pathologists jobs marketplace webinars sign up for our magazine subscribe contact cap today general question or request submit q a question submit letter to editor advertising follow us linkedin youtube cap today 325 waukegan road northfield il 60093 2026 cap today all rights reserved privacy policy submit type above and press enter to search press esc to cancel you can t add more product in compare x